Celularity Inc. (CELU) Financials

CELU Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 114.2 million 134.3 million
June 30, 2025 120.3 million 145.8 million
March 31, 2025 128.9 million 134.4 million
Dec. 31, 2024 132.7 million 123.8 million

CELU Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -4.2 million 2.0 million
June 30, 2025 -999000 2.4 million
March 31, 2025 -3.0 million 2.6 million
Dec. 31, 2024 1.5 million 3.1 million

CELU Net Income

No data available :(

CELU Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 120000 - 61.0 million
June 30, 2025 863000 36.5 million 26.7 million
March 31, 2025 293000 36.5 million 26.6 million
Dec. 31, 2024 738000 35.9 million 26.5 million

CELU Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 26.3 million
June 30, 2025 24.0 million
March 31, 2025 22.4 million
Dec. 31, 2024 22.5 million

CELU Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 56000 4.6 million 9.3 million -
June 30, 2025 - 3.4 million 12.6 million -
March 31, 2025 56000 3.7 million 14.3 million 23000
Dec. 31, 2024 56000 3.8 million 16.1 million 23000

CELU Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 5.3 million 2.0 million
June 30, 2025 5.7 million 5.2 million
March 31, 2025 11.4 million 3.6 million
Dec. 31, 2024 18.1 million 7.3 million

CELU Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CELU

Price: $0.75

52 week price:
0.69
4.35

Earnings Per Share: -3.33 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 396900

Market Capitalization: 25.0 million

Links: